GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hainan Huluwa Pharmaceutical Group Co Ltd (SHSE:605199) » Definitions » Price-to-Operating-Cash-Flow

Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) Price-to-Operating-Cash-Flow : 1,885.00 (As of May. 24, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Hainan Huluwa Pharmaceutical Group Co Price-to-Operating-Cash-Flow?

As of today (2024-05-24), Hainan Huluwa Pharmaceutical Group Co's share price is ¥11.31. Hainan Huluwa Pharmaceutical Group Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.01. Hence, Hainan Huluwa Pharmaceutical Group Co's Price-to-Operating-Cash-Flow Ratio for today is 1,885.00.

The historical rank and industry rank for Hainan Huluwa Pharmaceutical Group Co's Price-to-Operating-Cash-Flow or its related term are showing as below:

SHSE:605199' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 22.12   Med: 60.83   Max: 2095
Current: 1885.01

During the past 8 years, Hainan Huluwa Pharmaceutical Group Co's highest Price-to-Operating-Cash-Flow Ratio was 2095.00. The lowest was 22.12. And the median was 60.83.

SHSE:605199's Price-to-Operating-Cash-Flow is ranked worse than
99.85% of 678 companies
in the Drug Manufacturers industry
Industry Median: 17.225 vs SHSE:605199: 1885.01

Hainan Huluwa Pharmaceutical Group Co's Cash Flow from Operations per share for the three months ended in Mar. 2024 was ¥-0.46. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.01.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Hainan Huluwa Pharmaceutical Group Co was -98.80% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 100.00% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 8.90% per year.

During the past 8 years, Hainan Huluwa Pharmaceutical Group Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 100.00% per year. The lowest was -74.30% per year. And the median was 25.80% per year.


Hainan Huluwa Pharmaceutical Group Co Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Hainan Huluwa Pharmaceutical Group Co's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hainan Huluwa Pharmaceutical Group Co Price-to-Operating-Cash-Flow Chart

Hainan Huluwa Pharmaceutical Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial - 2,680.00 97.34 27.38 210.56

Hainan Huluwa Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.02 23.92 41.54 210.56 2,050.00

Competitive Comparison of Hainan Huluwa Pharmaceutical Group Co's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Hainan Huluwa Pharmaceutical Group Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hainan Huluwa Pharmaceutical Group Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hainan Huluwa Pharmaceutical Group Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Hainan Huluwa Pharmaceutical Group Co's Price-to-Operating-Cash-Flow falls into.



Hainan Huluwa Pharmaceutical Group Co Price-to-Operating-Cash-Flow Calculation

Hainan Huluwa Pharmaceutical Group Co's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=11.31/0.006
=1,885.00

Hainan Huluwa Pharmaceutical Group Co's Share Price of today is ¥11.31.
Hainan Huluwa Pharmaceutical Group Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Hainan Huluwa Pharmaceutical Group Co Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Hainan Huluwa Pharmaceutical Group Co's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Yaogu 4th Road, Phase II, Yaogu Industrial Park, Haikou National High-tech Zone, Hainan Province, Haikou, CHN, 570300
Hainan Huluwa Pharmaceutical Group Co Ltd is engaged in production and sales of Chinese patent medicines and chemical drugs. The company produces medicines for children's respiratory and digestive systems. Its products include star products, calabash, gourd dad, and gourd mom.

Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) Headlines

No Headlines